Q3 2024 Earnings Call Transcript November 4, 2024 Verona Pharma plc beats earnings expectations. Reported EPS is $-0.08819, ...

Q3 2024 Earnings Call Transcript November 4, 2024 Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $0.08, expectations were $-0.06. Operator: Good afternoon, and welcome to Castle ...

ANDOVER, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that Wissam Jabre, EVP and ...

Seaport Therapeutics ("Seaport or the "Company"), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the ...

US stocks rallied Tuesday as Wall Street awaited the results of a closely contested presidential race. The Dow rose over 425 ...

The consensus rating for Gilead Sciences is Neutral, based on 16 analyst ratings. With an average one-year price target of $84.25, there's a potential 6.22% downside.

Steep revenue drop in H1 2024 and high cash burn from operations fuel the current pessimism around Plug Power stock. Find out ...

Two-year yields climbed to 4.245%, from 4.189% late n New York. S&P 500 futures were up 0.5% in choppy trading, while Nasdaq ...

U.S. stock futures and the dollar surged in Asia on Wednesday as investors wagered Republican Donald Trump could win the U.S.

IPC Indice de Precios Y Cotizaciones 50,723.32-159.22-0.31% ...

Analyzing Alphabet's Q3 2024 results, strong revenue growth, robust balance sheet, Waymo's value, and projected EPS growth.

Read more on the potential for growth stocks correction. See why we should consider SCHD ETF for its balanced investment ...